European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 149, Issue 2 , Pages 131-135 , April 2010

Topical non-barrier agents for postoperative adhesion prevention in animal models

  • Atsushi Imai

      Affiliations

    • Institute of Endocrine-Related Cancer, Matsunami General Hospital, Kasamatsu Gifu 501-6062, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 582388 0111.
    • ,
  • Noriko Suzuki

      Affiliations

    • Department of Obstetrics and Gynecology Gifu University School of Medicine, Gifu 501-1194 Japan

Received 6 August 2009 ,Revised 8 December 2009 ,Accepted 21 December 2009.

References 

  1. Alpay Z, Saed G, Diamond M. Postoperative adhesions: from formation to prevention. Semin Reprod Med. 2008;26:13–21
  2. González-Quintero V, Cruz-Pachano F. Preventing adhesions in obstetric and gynecologic surgical procedures. Rev Obstet Gynecol. 2009;2:38–45
  3. van der Wal J, Jeekel J. The use of statins in postoperative adhesion prevention. Ann Surg. 2007;245:185–186
  4. Dai Z, Zou X, Chen G. Poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) as an injectable implant system for prevention of post-surgical tissue adhesion. Biomaterials. 2009;30:3075–3083
  5. The Practice Committee of the American Society for Reproductive Medicine. The Society of Reproductive Surgeons: Pathogenesis, consequences, and control of peritoneal adhesions in gynecologic surgery. Fertil Steril. 2007;88:21–26
  6. Irkorucu O, Ferahköşe Z, Memiş L, Ekinci O, Akin M. Reduction of post-surgical adhesions in a rat model: a comparative study. Clinics (Sao Paulo). 2009;64:143–148
  7. diZerega G, Tulandi T. Prevention of intra-abdominal adhesions in gynaecological surgery. Reprod Biomed Online. 2008;17:303–306
  8. Shavell V, Saed G, Diamond M. Review: cellular metabolism: contribution to postoperative adhesion development. Reprod Sci. 2009;16:627–634
  9. DeWilde R, Trew G. Postoperative abdominal adhesions and their prevention in gynaecological surgery. Expert concensus potion. Gynecol Surg. 2007;4:161–168
  10. Holmdahl L, Risberg B, Beck D, et al. Adhesions: pathogenesis and prevention-panel discussion and summary. Eur J Surg Suppl. 1997;163:56–62
  11. Aarons C, Cohen P, Gower A, et al. Statins (HMG-CoA reductase inhibitors) decrease postoperative adhesions by increasing peritoneal fibrinolytic activity. Ann Surg. 2007;245:176–184
  12. Endres M. Statins: Potential new indications in inflammatory conditions. Atheroscler Suppl. 2006;7:31–35
  13. Liao J, Laufs U. Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol. 2005;45:89–118
  14. Haslinger B, Goedde M, Toet K, Kooistra T. Simvastatin increases fibrinolytic activity in human peritoneal mesothelial cells independent of cholesterol lowering. Kidney Int. 2002;62:1611–1619
  15. Haslinger B, Kleemann R, Toet K, Kooistra T. Simvastatin suppresses tissue factor expression and increases fibrinolytic activity in tumor necrosis factor-alpha-activated human peritoneal mesothelial cells. Kidney Int. 2003;63:2065–2074
  16. Ghittoni R, Patrussi L, Pirozzi K, et al. Simvastatin inhibits t-cell activation by selectively impairing the function of ras superfamily GTPases. FASEB J. 2005;19:605–607
  17. Kusama T, Mukai M, Iwasaki T, et al. Inhibition of epidermal growth factor-induced RhoA translocation and invasion of human pancreatic cancer cells by 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. Cancer Res. 2001;61:4885–4891
  18. Suzuki N, Imai A: HMG-CoA reductase inhibitor lovastatin up-regulates plasminogen activator production through rhoa-signaling in peritoneal cell line Met5A. Gynecol Surg :in press, doi:10.1007/s10397-009-0546-7.
  19. Imai A, Tamaya T. GnRH receptor and apoptotic signaling. Vitam Horm. 2000;59:1–33
  20. Lydia W, Cheung T, Wong A. Gonadotropin-releasing hormone: GnRH receptor signaling in extrapituitary tissues. FEBS J. 2009;275:5479–5495
  21. Schindler A. Gonadotropin-releasing hormone agonists for prevention of postoperative adhesions: an overview. Gynecol Endocrinol. 2004;19:51–55
  22. Grow D, Coddington C, Hsiu J, Mikich Y, Hodgen G. Role of hypoestrogenism or sex steroid antagonism in adhesion formation after myometrial surgery in primates. Fertil Steril. 1996;66:140–147
  23. Wright J, Sharpe-Timms K. Gonadotropin-releasing hormone agonist therapy reduces postoperative adhesion formation and reformation after adhesiolysis in rat models for adhesion formation and endometriosis. Fertil Steril. 1995;63:1094–1100
  24. Sharpe-Timms K, Zimmer R, Jolliff W, Wright J, Nothnick W, Curry T. Gonadotropin-releasing hormone agonist (GnRH-a) therapy alters activity of plasminogen activators, matrix metalloproteinases, and their inhibitors in rat models for adhesion formation and endometriosis: potential GnRH-a-regulated mechanisms reducing adhesion formation. Fertil Steril. 1998;69:916–923
  25. Wiczyk H, Grow D, Adams L, O'Shea D, Reece M. Pelvic adhesions contain sex steroid receptors and produce angiogenesis growth factors. Fertil Steril. 1998;69:511–516
  26. Chegini N. TGF-beta system: the principal profibrotic mediator of peritoneal adhesion formation. Semin Reprod Med. 2008;26:298–312
  27. Diamond M, El-Hammady E, Wang R, Saed G. Regulation of transforming growth factor-beta, type III collagen, and fibronectin by dichloroacetic acid in human fibroblasts from normal peritoneum and adhesions. Fertil Steril. 2003;79:1161–1167
  28. Sugiyama M, Imai A, Takahashi S, Hirano S, Furui T, Tamaya T. Advanced indications for gonadotropin-releasing hormone (GnRH) analogues in gynecological oncology. Int J Oncol. 2003;23:445–452
  29. Winkler U, Bühler K, Koslowski S, Oberhoff C, Schindler A. Plasmatic haemostasis in gonadotrophin-releasing hormone analogue therapy: Effects of leuprorelin acetate depot on coagulatory and fibrinolytic activities. Clin Ther. 1992;14(Suppl A):114–120
  30. Ara C, Kirimlioglu H, Karabulut A, et al. Protective effect of melatonin against oxidative stress on adhesion formation in the rat cecum and uterine horn model. Life Sci. 2005;77:1341–1350
  31. Bubenik G, Blask D, Brown G, et al. Prospects of the clinical utilization of melatonin. Biol Signals Recept. 1998;7:195–219
  32. Gitto E, Pellegrino S, Gitto P, Barberi I, Reiter R. Oxidative stress of the newborn in the pre- and postnatal period and the clinical utility of melatonin. J Pineal Res. 2009;46:128–139
  33. Koc O, Duran B, Topcuoglu A, Bugdayci G, Yilmaz F, Dönmez M. Intraperitoneal administration of single dose type I collagen or low dose melatonin to prevent intraperitoneal adhesion formation: a comparative study. Eur J Obstet Gynecol Reprod Biol. 2009;145:209–213
  34. Ozçelik B, Serin I, Basbug M, Uludag S, Narin F, Tayyar M. Effect of melatonin in the prevention of postoperative adhesion formation in a rat uterine horn adhesion model. Hum Reprod. 2003;18:1703–1706
  35. Saeidi M, Sobhani R, Movahedi M, Alsaeidi S, Samani R. Effect of melatonin in the prevention of postoperative pericardial adhesion formation. Interact Cardiovasc Thorac Surg. 2009;9:26–28
  36. Saed G, Diamond M. Hypoxia-induced irreversible up-regulation of type I collagen and transforming growth factor-beta1 in human peritoneal fibroblasts. Fertil Steril. 2002;78:144–147
  37. Newman M, Baratta L, Swartz K. Activated, type I collagen (celleraterx) and its effectiveness in healing recalcitrant diabetic wounds: a case presentation. Adv Skin Wound Care. 2008;21:370–374
  38. Schönlebe F, Reck T, Tannapfel A, Werner H, Schneider I. Collagen foil (tissufoile) reduces the formation of adhesions when using polypropylene mesh for the repair of experimental abdominal wall defects. Int J Colorectal Dis. 2006;21:840–846
  39. Ar’Rajab A, Ahrén B, Rozga J, Bengmark S. Phosphatidylcholine prevents postoperative peritoneal adhesions: An experimental study in the rat. J Surg Res. 1991;50:212–215
  40. Manfredi R. Update on the appropriate use of linezolid in clinical practice. Ther Clin Risk Manage. 2006;2:455–464
  41. Aytan H, Caliskan A, Yener T, Demirturk F, Aytan P, Yenisehirli A. A novel antibiotic, linezolid, reduces intraperitoneal adhesion formation in the rat uterine horn model. Acta Obstet Gynecol Scand. 2009;88:781–786
  42. Erguder B, Kilicoglu S, Namuslu M, et al. Honey prevents hepatic damage induced by obstruction of the common bile duct. World J Gastroenterol. 2008;14:3729–3732
  43. Aysan E, Ayar E, Aren A, Cifter C. The role of intraperitoneal honey administration in preventing postoperative peritoneal adhesions. Eur J Obstet Gynecol Reprod Biol. 2002;104:152–155
  44. Emre A, Akin M, Isikgonul I, Yuksel O, Anadol A, Cifter C. Comparison of intraperitoneal honey and sodium hyaluronate-carboxymethylcellulose (seprafilm) for the prevention of postoperative intra-abdominal adhesions. Clinics (Sao Paulo). 2009;64:363–368
  45. Hosie K, Gilbert J, Kerr D, Brown C, Peers E. Fluid dynamics in man of an intraperitoneal drug delivery solution: 4% icodextrin. Drug Deliv. 2001;8:9–12
  46. Lang R, Grüntzig P, Weisgerber C, Weis C, Odermatt E, Kirschner M. Polyvinyl alcohol gel prevents abdominal adhesion formation in a rabbit model. Fertil Steril. 2007;88:1180–1186
  47. Kumar S, Wong P, Leaper D. Intraperitoneal prophylactic agents for preventing adhesions and adhesive intestinal obstruction after non-gynaecological abdominal surgery. Cochrane Database Syst Rev. 2009;21:CD005080
  48. Pierce R, Perrone J, Nimeri A, et al. 120-day comparative analysis of adhesion grade and quantity, mesh contraction, and tissue response to a novel omega-3 fatty acid bioabsorbable barrier macroporous mesh after intraperitoneal placement. Surg Innov. 2009;16:46–54
  49. Uludag M, Citgez B, Ozkaya O, et al. Effects of amniotic membrane on the healing of normal and high-risk colonic anastomoses in rats. Int J Colorectal Dis. 2009;24:809–817
  50. Coddington C, Grow D, Ahmed M, Toner J, Cook E, Diamond M. Gonadotropin-releasing hormone agonist pretreatment did not decrease postoperative adhesion formation after abdominal myomectomy in a randomized control trial. Fertil Steril. 2009;91:1909–1913
  51. Imai A, Takagi H, Matsunami K, Suzuki N. The use of statins in postoperative adhesion prevention. J Jnp Med Assoc. 2009;138:1813–1816(Japanese)

PII: S0301-2115(09)00748-9

doi: 10.1016/j.ejogrb.2009.12.026

European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 149, Issue 2 , Pages 131-135 , April 2010

Article Tools

* Image Usage & Resolution